Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma Academic Article Article uri icon


MeSH Major

  • General Surgery
  • Neoplasms


  • Despite optimal multimodality therapy, 23% of the patients in this series with primary extremity sarcoma developed distant metastasis. Median survival after metastasis was approximately 1 year. After metastasis, the independent favorable factors that are associated with patient survival include resection of the metastases, a long disease free interval, the absence of preceding local recurrence, and patient age < 50 years. Although a definitive conclusion regarding the benefit of resection can be made only with a randomized clinical trial, these data suggest that resection of metastatic STS may contribute to patient survival, which in some cases may be long term.

publication date

  • February 2, 1999



  • Academic Article


Digital Object Identifier (DOI)

  • 10.1002/(SICI)1097-0142(19990115)85:2<389::AID-CNCR17>3.0.CO;2-J

PubMed ID

  • 10023707

Additional Document Info

start page

  • 389

end page

  • 95


  • 85


  • 2